K. Tsuruga

E. Ito, T. Matsumiya, T. Imaizumi, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose.

H. Tanaka, K. Tsuruga, E. Ito, 2009, Clinical nephrology.

Addition of mizoribine to the prednisolone plus tacrolimus treatment regimen in a patient with lupus flare

E. Ito, Hiroshi Tanaka, K. Tsuruga, 2012, Rheumatology International.

Mizoribine Treatment of Young Patients with Severe Lupus Nephritis: A Clinicopathologic Study by the Tohoku Pediatric Study Group

H. Matsukura, J. Suzuki, Hiroshi Tanaka, 2008, Nephron Clinical Practice.

Long‐term intermittent pulse therapy with mizoribine attenuates histologic progression in young patients with severe lupus nephritis: Report of two patients (Brief Communication)

E. Ito, Koichi Suzuki, K. Tsugawa, 2007, Nephrology.

Intravenous immunoglobulin therapy leading to dramatic improvement in a patient with systemic juvenile idiopathic arthritis and severe pericarditis resistant to steroid pulse therapy

E. Ito, Hiroshi Tanaka, K. Tsuruga, 2012, Rheumatology International.

Alteration in the podoplanin–ezrin–cytoskeleton linkage is an important initiation event of the podocyte injury in puromycin aminonucleoside nephropathy, a mimic of minimal change nephrotic syndrome

H. Kawachi, E. Ito, H. Kaneko, 2015, Cell and Tissue Research.

Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy

K. Nakanishi, Takuhito Nagai, K. Iijima, 2014, Clinical and Experimental Nephrology.

H. Kawachi, E. Ito, H. Kaneko, 2015, Cell and Tissue Research.

Urinary excretion of sphingomyelinase phosphodiesterase acid‐like 3b in children with intractable nephrotic syndrome

T. Imaizumi, K. Tsugawa, Hiroshi Tanaka, 2017, Pediatrics international : official journal of the Japan Pediatric Society.

Complete clinical resolution of a Japanese family with renal pseudohypoaldosteronism type 1 due to a novel NR3C2 mutation

E. Sohara, S. Uchida, Takayasu Mori, 2019, Nephrology.

Interferon (IFN)-Induced Protein 35 (IFI35), a Type I Interferon-Dependent Transcript, Upregulates Inflammatory Signaling Pathways by Activating Toll-Like Receptor 3 in Human Mesangial Cells

M. Murakami, T. Matsumiya, Ryo Hayakari, 2016, Kidney and Blood Pressure Research.

Rebamipide reduces amyloid-β 1–42 (Aβ42) production and ameliorates Aβ43-lowered cell viability in cultured SH-SY5Y human neuroblastoma cells

T. Matsumiya, Ryo Hayakari, T. Imaizumi, 2017, Neuroscience Research.

End-stage kidney at the onset of nephrotic syndrome in a 4-year-old girl.

E. Ito, Koichi Suzuki, K. Tsugawa, 2003, The Tohoku journal of experimental medicine.

Carnosic acid suppresses the production of amyloid-β 1-42 and 1-43 by inducing an α-secretase TACE/ADAM17 in U373MG human astrocytoma cells

K. Itoh, T. Matsumiya, F. Xing, 2014, Neuroscience Research.

Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy

K. Nakanishi, Takuhito Nagai, K. Iijima, 2015, Clinical and Experimental Nephrology.

Severe post‐streptococcal acute glomerulonephritis and periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome

E. Ito, T. Oda, K. Joh, 2013, Pediatrics international : official journal of the Japan Pediatric Society.

Severe poststreptococcal acute glomerulonephritis and periodic fever with aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome: A case report

E. Ito, T. Oda, K. Joh, 2013 .

Mizoribine in the treatment of pediatric-onset glomerular disease

Hiroshi Tanaka, K. Tsuruga, Taddatsu Imaizumi, 2015, World Journal of Pediatrics.

Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome

E. Ito, Hiroshi Tanaka, K. Tsuruga, 2011, Pediatric Nephrology.

A novel multidrug therapy for difficult cyclosporine-resistant focal segmental glomerulosclerosis

Koichi Suzuki, K. Tsugawa, Hiroshi Tanaka, 2009, Pediatric Nephrology.

Toll-Like Receptor 3 Signaling Contributes to Regional Neutrophil Recruitment in Cultured Human Glomerular Endothelial Cells

H. Kijima, Qiang Liu, T. Matsumiya, 2018, Nephron.

Cylindromatosis (CYLD), a Deubiquitinase, Attenuates Inflammatory Signaling Pathways by Activating Toll-Like Receptor 3 in Human Mesangial Cells

T. Matsumiya, Ryo Hayakari, T. Imaizumi, 2017, Kidney and Blood Pressure Research.

Melanoma differentiation-associated gene 5 regulates the expression of a chemokine CXCL10 in human mesangial cells: implications for chronic inflammatory renal diseases.

T. Matsumiya, F. Xing, Ryo Hayakari, 2012, The Tohoku journal of experimental medicine.

ANTI‐INFLAMMATORY TREATMENT FOR POST‐DIARRHOEAL HAEMOLYTIC–URAEMIC SYNDROME WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT

E. Ito, H. Fujita, Hiroshi Tanaka, 2010, Nephrology.

Severe intrinsic acute kidney injury associated with therapeutic doses of acetaminophen

E. Ito, K. Joh, Hiroshi Tanaka, 2015, Pediatrics international : official journal of the Japan Pediatric Society.

A young girl with refractory intestinal Behçet’s disease: a case report and review of literatures on pediatric cases who received an anti-tumor necrosis factor agent

E. Ito, Hiroshi Tanaka, K. Tsuruga, 2013, Rheumatology International.

Clarithromycin attenuates the expression of monocyte chemoattractant protein-1 by activating toll-like receptor 4 in human mesangial cells

T. Imaizumi, H. Yoshida, K. Tsugawa, 2017, Clinical and Experimental Nephrology.

Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy

E. Ito, Koichi Suzuki, K. Tsugawa, 2004, Pediatrics international : official journal of the Japan Pediatric Society.

Long‐term clinicopathologic observation in a case of steroid‐resistant nephrotic syndrome caused by a novel Crumbs homolog 2 mutation

H. Tsukaguchi, K. Nozu, K. Iijima, 2018, Nephrology.

Benefits of once-daily administration of cyclosporine a for children with steroid-dependent, relapsing nephrotic syndrome.

E. Ito, Koichi Suzuki, Hiroshi Tanaka, 2010, The Tohoku journal of experimental medicine.

Gnetin C, a resveratrol dimer, reduces amyloid-β 1-42 (Aβ42) production and ameliorates Aβ42-lowered cell viability in cultured SH-SY5Y human neuroblastoma cells.

T. Matsumiya, Ryo Hayakari, T. Imaizumi, 2018, Biomedical research.

EFFICACY OF MIZORIBINE FOR STEROID‐RESISTANT MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS TYPE III

E. Ito, Hiroshi Tanaka, K. Tsuruga, 2010, Nephrology.

Carnosic acid attenuates apoptosis induced by amyloid-β 1–42 or 1–43 in SH-SY5Y human neuroblastoma cells

K. Itoh, T. Matsumiya, F. Xing, 2015, Neuroscience Research.

Dysgerminoma developing from an ectopic ovary in a patient with WAGR syndrome: A case report

E. Ito, H. Mizunuma, Y. Yokoyama, 2016, Molecular and clinical oncology.

Mizoribine for the treatment of lupus nephritis in children and adolescents.

K. Tsugawa, H. Tanaka, K. Tsuruga, 2004, Clinical Nephrology.

Monitoring of Epstein–Barr virus load and killer T cells in patients with juvenile idiopathic arthritis treated with methotrexate or tocilizumab

M. Fujieda, M. Daibata, Wataru Tamaki, 2017, Modern rheumatology.

Interaction between Interferon-Stimulated Gene 56 and Melanoma Differentiation-Associated Gene 5 in Toll-Like Receptor 3 Signaling in Normal Human Mesangial Cells

T. Matsumiya, F. Xing, Ryo Hayakari, 2013, American Journal of Nephrology.

Does Dent disease remain an underrecognized cause for young boys with focal glomerulosclerosis?

E. Ito, K. Joh, K. Tsugawa, 2016, Pediatrics international : official journal of the Japan Pediatric Society.

Interferon-Stimulated Gene 15, a Type I Interferon-Dependent Transcript, Is Involved in a Negative Feedback Loop in Innate Immune Reactions in Human Mesangial Cells

M. Murakami, T. Matsumiya, T. Imaizumi, 2016, Nephron.

Successful multidrug treatment of a pediatric patient with severe Churg-Strauss syndrome refractory to prednisolone.

E. Ito, Hiroshi Tanaka, K. Tsuruga, 2011, The Tohoku journal of experimental medicine.

Glomerular expression of myxovirus resistance protein 1 in human mesangial cells: Possible activation of innate immunity in the pathogenesis of lupus nephritis

E. Ito, T. Matsumiya, T. Imaizumi, 2013, Nephrology.

Tumor necrosis factor-α synergistically enhances polyinosinic-polycytidylic acid-induced toll-like receptor 3 signaling in cultured normal human mesangial cells: possible involvement in the pathogenesis of lupus nephritis

T. Matsumiya, F. Xing, Ryo Hayakari, 2015, Clinical and Experimental Nephrology.

Mizoribine selectively attenuates monocyte chemoattractant protein‐1 production in cultured human glomerular mesangial cell: A possible benefit of its use in the treatment of lupus nephritis

T. Matsumiya, T. Imaizumi, H. Yoshida, 2014, Nephrology.

Carnosic acid attenuates apoptosis induced by amyloid-β 1–42 or 1–43 in SH-SY5Y human neuroblastoma cells

K. Itoh, T. Matsumiya, F. Xing, 2015, Neuroscience Research.

Polyinosinic-Polycytidylic Acid Induces the Expression of Interferon-Stimulated Gene 20 in Mesangial Cells

F. Sato, T. Matsumiya, Ryo Hayakari, 2011, Nephron Experimental Nephrology.

Retinoic acid-inducible gene-I is induced by double-stranded RNA and regulates the expression of CC chemokine ligand (CCL) 5 in human mesangial cells.

E. Ito, T. Matsumiya, T. Imaizumi, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Long-Term Tacrolimus-Based Immunosuppressive Treatment for Young Patients with Lupus Nephritis: A Prospective Study in Daily Clinical Practice

E. Ito, N. Kumagai, Hiroshi Tanaka, 2013, Nephron Clinical Practice.

Single dose of rituximab for pediatric-onset refractory systemic lupus erythematosus

H. Tanaka, K. Tsuruga, F. Ikeda, 2013, Lupus.